RAPT Therapeutics (RAPT) Announced Proposed Offering of $125M Worth of Shares

Go back to RAPT Therapeutics (RAPT) Announced Proposed Offering of $125M Worth of Shares

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

June 14, 2021 4:01 PM EDT

SOUTH SAN FRANCISCO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that it has commenced an underwritten public offering of $125 million of its common stock. In addition, RAPT expects the underwriters to be granted a 30-day option to purchase up to an additional $18.75 million of its common stock on the same terms and conditions. All of the shares of common... More